Loading company…
Neovacs SA is a French biotechnology company developing Kinoïde immunotherapies for lupus and allergies.
Based in Suresnes, France, Neovacs SA develops immunotherapies on its Kinoïde technology platform. Its products include Kinoïde IFNa for lupus and Kinoïde IL-4/IL-13/IgE for allergies. The company has completed 14 funding deals, and its latest round was a PIPE of EUR 8.000 mn, which is also its total raised.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in